AAAAAA

   
Results: 1-18 |
Results: 18
Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice
Authors: Xiang, R Silletti, S Lode, HN Dolman, CS Ruehlmann, JM Niethammer, AG Pertl, U Gillies, SD Primus, FJ Reisfeld, RA
Citation: R. Xiang et al., Protective immunity against human carcinoembryonic antigen (CEA) induced by an oral DNA vaccine in CEA-transgenic mice, CLIN CANC R, 7(3), 2001, pp. 856S-864S
Strong-light photoinhibition treatment accelerates the changes of protein secondary structures in triton-treated photosystem I and photosystem II complexes
Authors: Xiang, R Xu, Q Mao, HB Li, GF Wei, J Gong, YD Kuang, TY Zhao, NM
Citation: R. Xiang et al., Strong-light photoinhibition treatment accelerates the changes of protein secondary structures in triton-treated photosystem I and photosystem II complexes, J PROTEIN C, 20(3), 2001, pp. 247-254
An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice
Authors: Niethammer, AG Primus, FJ Xiang, R Dolman, CS Ruehlmann, JM Ba, Y Gillies, SD Reisfeld, RA
Citation: Ag. Niethammer et al., An oral DNA vaccine against human carcinoembryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice, VACCINE, 20(3-4), 2001, pp. 421-429
A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancerin carcinoembryonic antigen-transgenic mice
Authors: Xiang, R Primus, FJ Ruehlmann, JM Niethammer, AG Silletti, S Lode, HN Dolman, CS Gillies, SD Reisfeld, RA
Citation: R. Xiang et al., A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T cell-mediated protective immunity against colon cancerin carcinoembryonic antigen-transgenic mice, J IMMUNOL, 167(8), 2001, pp. 4560-4565
The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy
Authors: Imboden, M Murphy, KR Rakhmilevich, AL Neal, ZC Xiang, R Reisfeld, RA Gillies, SD Sondel, PM
Citation: M. Imboden et al., The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy, CANCER RES, 61(4), 2001, pp. 1500-1507
MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma
Authors: Ruehlmann, JM Xiang, R Niethammer, AG Ba, Y Perti, U Dolman, CS Gillies, SD Reisfeld, RA
Citation: Jm. Ruehlmann et al., MIG (CXCL9) chemokine gene therapy combines with antibody-cytokine fusion protein to suppress growth and dissemination of murine colon carcinoma, CANCER RES, 61(23), 2001, pp. 8498-8503
Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma
Authors: Niethammer, AG Xiang, R Ruehlmann, JM Lode, HN Dolman, CS Gillies, SD Reisfeld, RA
Citation: Ag. Niethammer et al., Targeted interleukin 2 therapy enhances protective immunity induced by an autologous oral DNA vaccine against murine melanoma, CANCER RES, 61(16), 2001, pp. 6178-6184
Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma
Authors: Lode, HN Pertl, U Xiang, R Gaedicke, G Reisfeld, RA
Citation: Hn. Lode et al., Tyrosine hydroxylase-based DNA-vaccination is effective against murine neuroblastoma, MED PED ONC, 35(6), 2000, pp. 641-646
Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma (vol 95, pg 2475, 1998)
Authors: Lode, HN Dreier, T Xiang, R Varki, NM Kang, AS Reisfeld, RA
Citation: Hn. Lode et al., Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma (vol 95, pg 2475, 1998), P NAS US, 97(7), 2000, pp. 3782-3782
An autologous oral DNA vaccine protects against murine melanoma (vol. 97, pg. 5492, 2000)
Authors: Xiang, R Lode, HN Chao, TH Ruehlmann, JM Dolman, CS Rodriguez, F Whitton, JL Overwijk, WW Restifo, NP Reisfeld, RA
Citation: R. Xiang et al., An autologous oral DNA vaccine protects against murine melanoma (vol. 97, pg. 5492, 2000), P NAS US, 97(23), 2000, pp. 12932-12932
An autologous oral DNA vaccine protects against murine melanoma
Authors: Xiang, R Lode, HN Chao, TH Ruehlmann, JM Dolman, CS Rodriguez, F Whitton, JL Overwijk, WW Restifo, NP Reisfeld, RA
Citation: R. Xiang et al., An autologous oral DNA vaccine protects against murine melanoma, P NAS US, 97(10), 2000, pp. 5492-5497
What to do with targeted IL-2
Authors: Lode, HN Xiang, R Perri, P Pertl, U Lode, A Gillies, SD Reisfeld, RA
Citation: Hn. Lode et al., What to do with targeted IL-2, DRUGS TODAY, 36(5), 2000, pp. 321-336
Brownian coagulation of fractal agglomerates: Analytical solution using the log-normal size distribution assumption
Authors: Park, SH Xiang, R Lee, KW
Citation: Sh. Park et al., Brownian coagulation of fractal agglomerates: Analytical solution using the log-normal size distribution assumption, J COLL I SC, 231(1), 2000, pp. 129-135
Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction
Authors: Lode, HN Xiang, R Pertl, U Forster, E Schoenberger, SP Gillies, SD Reisfeld, RA
Citation: Hn. Lode et al., Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interaction, J CLIN INV, 105(11), 2000, pp. 1623-1630
Enantiomer separations of phenylephrine and synephrine by capillary electrochromatography on bare silica stationary phase using hydroxypropyl-beta-cyclodextrin as a mobile phase additive
Authors: Wei, W Luo, GA Xiang, R Yan, C
Citation: W. Wei et al., Enantiomer separations of phenylephrine and synephrine by capillary electrochromatography on bare silica stationary phase using hydroxypropyl-beta-cyclodextrin as a mobile phase additive, J MICROCOL, 11(4), 1999, pp. 263-269
Synergy between an antiangiogenic integrin alpha(v) antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases
Authors: Lode, HN Moehler, T Xiang, R Jonczyk, A Gillies, SD Cheresh, DA Reisfeld, RA
Citation: Hn. Lode et al., Synergy between an antiangiogenic integrin alpha(v) antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases, P NAS US, 96(4), 1999, pp. 1591-1596
Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12
Authors: Lode, HN Xiang, R Duncan, SR Theofilopoulos, AN Gillies, SD Reisfeld, RA
Citation: Hn. Lode et al., Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12, P NAS US, 96(15), 1999, pp. 8591-8596
T cell memory against colon carcinoma is long-lived absence of antigen
Authors: Xiang, R Lode, HN Gillies, SD Reisfeld, RA
Citation: R. Xiang et al., T cell memory against colon carcinoma is long-lived absence of antigen, J IMMUNOL, 163(7), 1999, pp. 3676-3683
Risultati: 1-18 |